Evidence map›Paper›PMID 42022804›Full record

ArticleFrontiers in cellular and infection microbiology2026

Epidemiology and risk factors of multidrug-resistant organisms in a Chinese tertiary hospital: a 10-year retrospective cohort study across the COVID-19 policy phases, 2013-2023.

Shanshan Yang, Meng Wei, Haixu Chen, Yazhuo Hu, Zheng Luo, Tingjian Cao, Xintong Nie, Ya Qiu

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shanshan Yang *Institute of Geriatrics, The 2nd Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Meng Wei *Institute of Geriatrics, The 2nd Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Haixu Chen *Institute of Geriatrics, The 2nd Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Yazhuo HuInstitute of Geriatrics, The 2nd Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Zheng LuoDepartment of Pulmonary and Critical Care Medicine, The 2nd Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Tingjian CaoInstitute of Geriatrics, The 2nd Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Xintong NieInstitute of Geriatrics, The 2nd Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Ya QiuInstitute of Geriatrics, The 2nd Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multidrug-resistant organism (MDRO) infections are a major global health threat. The COVID-19 pandemic and related containment policies may have altered hospital infection epidemiology and the distribution of MDROs. Methods: In this retrospective cohort study, clinical and microbiological data from 2,669 adult inpatients with culture-confirmed hospital-acquired infections between 2013 and 2023 were analyzed. MDROs were defined per CLSI guidelines. The study period was stratified into pre-pandemic, strict containment, and post-adjustment phases. Multivariate logistic regression was used to identified factors associated with specific MDRO infections. Results: The overall MDRO detection rate increased from 36.9% to 56.4% during the strict containment. CRAB, which had previously been the dominant resistant pathogen, was progressively overtaken by CRE, while Conclusions: Hospital MDRO epidemiology shifted substantially across the COVID-19 policy phases, with CRE emerging as the dominant resistant pathogen. Specific invasive procedures showed pathogen-specific associations, supporting risk stratification and more targeted infection prevention strategies in high-risk hospitalized patients.

Indexed as

Bacterial InfectionsCOVID-19Cross InfectionDrug Resistance, Multiple, BacterialAdultAgedChinaEast Asian PeopleFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSARS-CoV-2Tertiary Care CentersCOVID-19CRABCREhospital-acquired infectionmultidrug-resistant organisms

Identifiers

PMID42022804
PMCPMC13095828

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.